Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DG
Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.